Table 4.
Detection of WMCs and CMHs with 3T MRI in Fighters, NHCs, and Patients With TBI
| Nos. of WMCs and CMHs | Fighters (n = 19) | 3T NHCs (n = 61) | Patients with TBI (n = 16a) | p value* | p value** |
|---|---|---|---|---|---|
| Reader 1 | |||||
| Median no. of WMCs [IQR] (range) | 1 [0, 6] (0, 37) | 0 [0, 0] (0, 12) | 4 [1, 8] (0, 100) | 0.004 | 0.166 |
| Median no. of CMHs [IQR] (range) | 0 [0, 0] (0, 2) | 0 [0, 0] (0, 2) | 0 [0, 0] (0, 30) | 0.054 | 1.000 |
| Reader 2 | |||||
| Median no. of WMCs [IQR] (range) | 3 [1, 8] (0, 41) | 0 [0, 0] (0, 15) | 6 [2, 10] (0, 140) | <0.001 | 0.229 |
| Median no. of CMHs [IQR] (range) | 0 [0, 0] (0, 8) | 0 [0, 0] (0, 1) | 0 [0, 1] (0, 40) | 0.027 | 0.641 |
*
Fighters versus NHCs.
**
Fighters versus patients with TBI.
a
Only 15 patients with TBI were assessed for WMCs.
WMCs, white matter changes; CMHs, cerebral microhemorrhages; T, Tesla; MRI, magnetic resonance imaging; NHCs, normal healthy controls; TBI, head trauma; IQR, interquartile range.